Clinical trial

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia…

NCT00003187 · Virginia Commonwealth University, Other · Completed

Key facts

NCT number NCT00003187
Title Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
Official title The Unrelated Donor Marrow Transplantation Trial
Lead sponsor Virginia Commonwealth University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Leukemia, Lymphoma, Myelodysplastic Syndromes
Intervention type Biological, Drug, Procedure, Radiation
Interventions filgrastim, cyclophosphamide, cyclosporine, cytarabine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy
Enrollment 19
Start date May 1, 1995
Primary completion Feb 1, 2005
Completion Feb 1, 2005
First posted May 24, 2004
Last update posted Feb 24, 2010
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies